ACASTI PHARMA INC (ACST) Stock Analyst Ratings
USA - NASDAQ:ACST - CA00430K8656 - Common Stock
3.37 USD
-0.03 (-0.88%)
3.38 USD
+0.01 (+0.3%)
ChartMill assigns a Buy % Consensus number of 83% to ACST. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.16. This target is 142.14% above the current price.
ACST was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ACST.
In the previous month the buy percentage consensus was at a similar level.
ACST was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-09-26 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-09-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-07 | Craig-Hallum | Initiate | Buy |
| 2023-02-15 | EF Hutton | Reiterate | Buy |
| 2022-12-19 | EF Hutton | Initiate | Buy |
| 2022-12-15 | HC Wainwright & Co. | Initiate | Buy |
| 2021-12-22 | Oppenheimer | Initiate | Outperform |
| 2021-12-21 | Oppenheimer | Initiate | Outperform |
ACASTI PHARMA INC / ACST FAQ
Can you provide the average price target for ACASTI PHARMA INC stock?
7 analysts have analysed ACST and the average price target is 8.16 USD. This implies a price increase of 142.14% is expected in the next year compared to the current price of 3.37.
What is the consensus rating for ACST stock?
The consensus rating for ACASTI PHARMA INC (ACST) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for ACST stock?
The number of analysts covering ACASTI PHARMA INC (ACST) is 7.